APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orally Disintegrating Tablet Excipient

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

Selected research

Industry Growth & Trends

Global Orally Disintegrating Tablet Excipient Industry Growth and Trends Forecast to 2032

19 December 2025111 pages

Choose your research edition.

Industry ResearchOrally Disintegrating Tablet Excipient Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Orally Disintegrating Tablet Excipient Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Orally Disintegrating Tablet Excipient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orally Disintegrating Tablet Excipient Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Orally Disintegrating Tablet Excipient Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Orally Disintegrating Tablet Excipient market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Orally Disintegrating Tablet Excipient market size, estimates, and forecasts are presented in terms of sales volume (K MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Orally Disintegrating Tablet Excipient market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Orally Disintegrating Tablet Excipient.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Orally Disintegrating Tablet Excipient market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Orally Disintegrating Tablet Excipient Market by Company

BASF

JRS Pharma

Roquette

ABF Ingredients

DFE Pharma

Evonik

Merck KGaA

Ashland

Meggle Pharma

Shin-Etsu

Fuji Chemical Industries

McePharma (Vivesa holding)

Cargill Incorporated

Daicel Corporation

Anhui Sunhere Pharmaceutical

Orally Disintegrating Tablet Excipient Segment by Type

Binders

Glidents

Diluents

Disintegrants

Others

Orally Disintegrating Tablet Excipient Segment by Application

Anti-Psychotics Drug

Anti-Epileptics Drug

Others

Orally Disintegrating Tablet Excipient Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orally Disintegrating Tablet Excipient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orally Disintegrating Tablet Excipient and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orally Disintegrating Tablet Excipient.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Orally Disintegrating Tablet Excipient manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Orally Disintegrating Tablet Excipient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Binders Table 2. Major Company of Glidents Table 3. Major Company of Diluents Table 4. Major Company of Disintegrants Table 5. Major Company of Others Table 6. Global Orally Disintegrating Tablet Excipient Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 8. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type (2021-2026) Table 9. Global Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (US$ Million) Table 10. Global Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type (2021-2026) Table 11. Global Orally Disintegrating Tablet Excipient Price by Type (2021-2026) & (USD/MT) Table 12. Global Orally Disintegrating Tablet Excipient Sales by Type (2027-2032) & (K MT) Table 13. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type (2027-2032) Table 14. Global Orally Disintegrating Tablet Excipient Sales by Type (2027-2032) & (US$ Million) Table 15. Global Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type (2027-2032) Table 16. Global Orally Disintegrating Tablet Excipient Price by Type (2027-2032) & (USD/MT) Table 17. North America Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 18. North America Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 20. Europe Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 22. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 24. Latin America Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 26. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (US$ Million) Table 27. Orally Disintegrating Tablet Excipient Industry Trends Table 28. Orally Disintegrating Tablet Excipient Industry Drivers Table 29. Orally Disintegrating Tablet Excipient Industry Opportunities and Challenges Table 30. Orally Disintegrating Tablet Excipient Industry Restraints Table 31. Global Orally Disintegrating Tablet Excipient Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2021-2026) Table 33. Global Orally Disintegrating Tablet Excipient Sales by Company (2021-2026) & (K MT) Table 34. Global Orally Disintegrating Tablet Excipient Sales Share by Company (2021-2026) Table 35. Global Orally Disintegrating Tablet Excipient Market Price by Company (2021-2026) & (USD/MT) Table 36. Global Orally Disintegrating Tablet Excipient Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Orally Disintegrating Tablet Excipient Major Company Production Sites and Headquarters Table 38. Global Orally Disintegrating Tablet Excipient Company, Product Type & Application Table 39. Global Orally Disintegrating Tablet Excipient Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Orally Disintegrating Tablet Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Orally Disintegrating Tablet Excipient Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Orally Disintegrating Tablet Excipient Sales by Region (2021-2026) & (K MT) Table 44. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Region (2021-2026) Table 45. Global Orally Disintegrating Tablet Excipient Sales by Region (2021-2026) & (US$ Million) Table 46. Global Orally Disintegrating Tablet Excipient Sales Market Share in Value by Region (2021-2026) Table 47. Global Orally Disintegrating Tablet Excipient Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 48. Global Orally Disintegrating Tablet Excipient Sales by Region (2027-2032) & (K MT) Table 49. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Region (2027-2032) Table 50. Global Orally Disintegrating Tablet Excipient Sales by Region (2027-2032) & (US$ Million) Table 51. Global Orally Disintegrating Tablet Excipient Sales Market Share in Value by Region (2027-2032) Table 52. Global Orally Disintegrating Tablet Excipient Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2027-2032) Table 53. Global Orally Disintegrating Tablet Excipient Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 55. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application (2021-2026) Table 56. Global Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (US$ Million) Table 57. Global Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application (2021-2026) Table 58. Global Orally Disintegrating Tablet Excipient Price by Application (2021-2026) & (USD/MT) Table 59. Global Orally Disintegrating Tablet Excipient Sales by Application (2027-2032) & (K MT) Table 60. Global Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application (2027-2032) Table 61. Global Orally Disintegrating Tablet Excipient Sales by Application (2027-2032) & (US$ Million) Table 62. Global Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application (2027-2032) Table 63. Global Orally Disintegrating Tablet Excipient Price by Application (2027-2032) & (USD/MT) Table 64. North America Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 65. North America Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 67. Europe Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 69. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 71. Latin America Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 73. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (US$ Million) Table 74. BASF Company Information Table 75. BASF Business Overview Table 76. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 77. BASF Orally Disintegrating Tablet Excipient Product Portfolio Table 78. BASF Recent Development Table 79. JRS Pharma Company Information Table 80. JRS Pharma Business Overview Table 81. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 82. JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio Table 83. JRS Pharma Recent Development Table 84. Roquette Company Information Table 85. Roquette Business Overview Table 86. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 87. Roquette Orally Disintegrating Tablet Excipient Product Portfolio Table 88. Roquette Recent Development Table 89. ABF Ingredients Company Information Table 90. ABF Ingredients Business Overview Table 91. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 92. ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio Table 93. ABF Ingredients Recent Development Table 94. DFE Pharma Company Information Table 95. DFE Pharma Business Overview Table 96. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 97. DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio Table 98. DFE Pharma Recent Development Table 99. Evonik Company Information Table 100. Evonik Business Overview Table 101. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 102. Evonik Orally Disintegrating Tablet Excipient Product Portfolio Table 103. Evonik Recent Development Table 104. Merck KGaA Company Information Table 105. Merck KGaA Business Overview Table 106. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 107. Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio Table 108. Merck KGaA Recent Development Table 109. Ashland Company Information Table 110. Ashland Business Overview Table 111. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 112. Ashland Orally Disintegrating Tablet Excipient Product Portfolio Table 113. Ashland Recent Development Table 114. Meggle Pharma Company Information Table 115. Meggle Pharma Business Overview Table 116. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 117. Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio Table 118. Meggle Pharma Recent Development Table 119. Shin-Etsu Company Information Table 120. Shin-Etsu Business Overview Table 121. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 122. Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio Table 123. Shin-Etsu Recent Development Table 124. Fuji Chemical Industries Company Information Table 125. Fuji Chemical Industries Business Overview Table 126. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 127. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio Table 128. Fuji Chemical Industries Recent Development Table 129. McePharma (Vivesa holding) Company Information Table 130. McePharma (Vivesa holding) Business Overview Table 131. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 132. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio Table 133. McePharma (Vivesa holding) Recent Development Table 134. Cargill Incorporated Company Information Table 135. Cargill Incorporated Business Overview Table 136. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 137. Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio Table 138. Cargill Incorporated Recent Development Table 139. Daicel Corporation Company Information Table 140. Daicel Corporation Business Overview Table 141. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 142. Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio Table 143. Daicel Corporation Recent Development Table 144. Anhui Sunhere Pharmaceutical Company Information Table 145. Anhui Sunhere Pharmaceutical Business Overview Table 146. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 147. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio Table 148. Anhui Sunhere Pharmaceutical Recent Development Table 149. North America Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 150. North America Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 151. North America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021-2026) Table 152. North America Orally Disintegrating Tablet Excipient Sales Forecast by Country (2027-2032) & (K MT) Table 153. North America Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Country (2027-2032) Table 154. North America Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. North America Orally Disintegrating Tablet Excipient Market Size by Country (2021-2026) & (US$ Million) Table 156. North America Orally Disintegrating Tablet Excipient Market Share by Country (2021-2026) Table 157. North America Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. North America Orally Disintegrating Tablet Excipient Market Share Forecast by Country (2027-2032) Table 159. Europe Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 160. Europe Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 161. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021-2026) Table 162. Europe Orally Disintegrating Tablet Excipient Sales Forecast by Country (2027-2032) & (K MT) Table 163. Europe Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Country (2027-2032) Table 164. Europe Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Europe Orally Disintegrating Tablet Excipient Market Size by Country (2021-2026) & (US$ Million) Table 166. Europe Orally Disintegrating Tablet Excipient Market Share by Country (2021-2026) Table 167. Europe Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Europe Orally Disintegrating Tablet Excipient Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 171. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021-2026) Table 172. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Forecast by Country (2027-2032) & (K MT) Table 173. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific Orally Disintegrating Tablet Excipient Market Size by Country (2021-2026) & (US$ Million) Table 176. Asia-Pacific Orally Disintegrating Tablet Excipient Market Share by Country (2021-2026) Table 177. Asia-Pacific Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Asia-Pacific Orally Disintegrating Tablet Excipient Market Share Forecast by Country (2027-2032) Table 179. Latin America Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 180. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 181. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021-2026) Table 182. Latin America Orally Disintegrating Tablet Excipient Sales Forecast by Country (2027-2032) & (K MT) Table 183. Latin America Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Country (2027-2032) Table 184. Latin America Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Latin America Orally Disintegrating Tablet Excipient Market Size by Country (2021-2026) & (US$ Million) Table 186. Latin America Orally Disintegrating Tablet Excipient Market Share by Country (2021-2026) Table 187. Latin America Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Latin America Orally Disintegrating Tablet Excipient Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 191. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021-2026) Table 192. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Forecast by Country (2027-2032) & (K MT) Table 193. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Country (2021-2026) & (US$ Million) Table 196. Middle East and Africa Orally Disintegrating Tablet Excipient Market Share by Country (2021-2026) Table 197. Middle East and Africa Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2027-2032) & (US$ Million) Table 198. Middle East and Africa Orally Disintegrating Tablet Excipient Market Share Forecast by Country (2027-2032) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Orally Disintegrating Tablet Excipient Distributors List Table 202. Orally Disintegrating Tablet Excipient Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Orally Disintegrating Tablet Excipient Image Figure 2. Global Orally Disintegrating Tablet Excipient Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orally Disintegrating Tablet Excipient Market Size (2021-2032) & (US$ Million) Figure 4. Global Orally Disintegrating Tablet Excipient Sales (2021-2032) & (K MT) Figure 5. Binders Image Figure 6. Global Binders Sales YoY Growth (2021-2032) & (K MT) Figure 7. Glidents Image Figure 8. Global Glidents Sales YoY Growth (2021-2032) & (K MT) Figure 9. Diluents Image Figure 10. Global Diluents Sales YoY Growth (2021-2032) & (K MT) Figure 11. Disintegrants Image Figure 12. Global Disintegrants Sales YoY Growth (2021-2032) & (K MT) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K MT) Figure 15. Global Orally Disintegrating Tablet Excipient Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Orally Disintegrating Tablet Excipient Market Share by Type 2025 VS 2032 Figure 17. North America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type in 2025 Figure 18. North America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type in 2025 Figure 19. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type in 2025 Figure 20. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type in 2025 Figure 23. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Orally Disintegrating Tablet Excipient Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Anti-Psychotics Drug Image Figure 30. Global Anti-Psychotics Drug Sales YoY Growth (2021-2032) & (K MT) Figure 31. Anti-Epileptics Drug Image Figure 32. Global Anti-Epileptics Drug Sales YoY Growth (2021-2032) & (K MT) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K MT) Figure 35. Global Orally Disintegrating Tablet Excipient Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Orally Disintegrating Tablet Excipient Market Share by Application 2025 VS 2032 Figure 37. North America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application in 2025 Figure 38. North America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application in 2025 Figure 39. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application in 2025 Figure 40. Europe Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application in 2025 Figure 43. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share in Value by Application in 2025 Figure 47. North America Orally Disintegrating Tablet Excipient Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 48. North America Orally Disintegrating Tablet Excipient Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Orally Disintegrating Tablet Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Orally Disintegrating Tablet Excipient Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Orally Disintegrating Tablet Excipient Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 52. Europe Orally Disintegrating Tablet Excipient Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Orally Disintegrating Tablet Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Orally Disintegrating Tablet Excipient Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 56. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Orally Disintegrating Tablet Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Orally Disintegrating Tablet Excipient Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Orally Disintegrating Tablet Excipient Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 60. Latin America Orally Disintegrating Tablet Excipient Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Orally Disintegrating Tablet Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Orally Disintegrating Tablet Excipient Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 64. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Orally Disintegrating Tablet Excipient Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Orally Disintegrating Tablet Excipient Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Orally Disintegrating Tablet Excipient Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Binders
  • Glidents
  • Diluents
  • Disintegrants
  • Others
Applications
  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Others
Companies covered
  • BASF
  • JRS Pharma
  • Roquette
  • ABF Ingredients
  • DFE Pharma
  • Evonik
  • Merck KGaA
  • Ashland
  • Meggle Pharma
  • Shin-Etsu
  • Fuji Chemical Industries
  • McePharma (Vivesa holding)
  • Cargill Incorporated
  • Daicel Corporation
  • Anhui Sunhere Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Orally Disintegrating Tablet Excipient Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Orally Disintegrating Tablet Excipient Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Orally Disintegrating Tablet Excipient Market by Type
  6. 1.3.1 Binders
  7. 1.3.2 Glidents
  8. 1.3.3 Diluents
  9. 1.3.4 Disintegrants
  10. 1.3.5 Others
  11. 1.4 Global Orally Disintegrating Tablet Excipient Market Size by Type
  12. 1.4.1 Global Orally Disintegrating Tablet Excipient Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Orally Disintegrating Tablet Excipient Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Orally Disintegrating Tablet Excipient Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Orally Disintegrating Tablet Excipient Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Orally Disintegrating Tablet Excipient Industry Trends
  2. 2.2 Orally Disintegrating Tablet Excipient Industry Drivers
  3. 2.3 Orally Disintegrating Tablet Excipient Industry Opportunities and Challenges
  4. 2.4 Orally Disintegrating Tablet Excipient Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Orally Disintegrating Tablet Excipient Revenue (2021-2026)
  2. 3.2 Global Top Players by Orally Disintegrating Tablet Excipient Sales (2021-2026)
  3. 3.3 Global Top Players by Orally Disintegrating Tablet Excipient Price (2021-2026)
  4. 3.4 Global Orally Disintegrating Tablet Excipient Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Orally Disintegrating Tablet Excipient Major Company Production Sites & Headquarters
  6. 3.6 Global Orally Disintegrating Tablet Excipient Company, Product Type & Application
  7. 3.7 Global Orally Disintegrating Tablet Excipient Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Orally Disintegrating Tablet Excipient Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Orally Disintegrating Tablet Excipient Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Orally Disintegrating Tablet Excipient Tier 1, Tier 2, and Tier 3
4 Orally Disintegrating Tablet Excipient Regional Status and Outlook
  1. 4.1 Global Orally Disintegrating Tablet Excipient Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Orally Disintegrating Tablet Excipient Historic Market Size by Region
  3. 4.2.1 Global Orally Disintegrating Tablet Excipient Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Orally Disintegrating Tablet Excipient Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Orally Disintegrating Tablet Excipient Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Orally Disintegrating Tablet Excipient Forecasted Market Size by Region
  7. 4.3.1 Global Orally Disintegrating Tablet Excipient Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Orally Disintegrating Tablet Excipient Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Orally Disintegrating Tablet Excipient Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Orally Disintegrating Tablet Excipient by Application
  1. 5.1 Orally Disintegrating Tablet Excipient Market by Application
  2. 5.1.1 Anti-Psychotics Drug
  3. 5.1.2 Anti-Epileptics Drug
  4. 5.1.3 Others
  5. 5.2 Global Orally Disintegrating Tablet Excipient Market Size by Application
  6. 5.2.1 Global Orally Disintegrating Tablet Excipient Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Orally Disintegrating Tablet Excipient Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Orally Disintegrating Tablet Excipient Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Orally Disintegrating Tablet Excipient Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BASF
  2. 6.1.1 BASF Company Information
  3. 6.1.2 BASF Business Overview
  4. 6.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BASF Orally Disintegrating Tablet Excipient Product Portfolio
  6. 6.1.5 BASF Recent Developments
  7. 6.2 JRS Pharma
  8. 6.2.1 JRS Pharma Company Information
  9. 6.2.2 JRS Pharma Business Overview
  10. 6.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio
  12. 6.2.5 JRS Pharma Recent Developments
  13. 6.3 Roquette
  14. 6.3.1 Roquette Company Information
  15. 6.3.2 Roquette Business Overview
  16. 6.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roquette Orally Disintegrating Tablet Excipient Product Portfolio
  18. 6.3.5 Roquette Recent Developments
  19. 6.4 ABF Ingredients
  20. 6.4.1 ABF Ingredients Company Information
  21. 6.4.2 ABF Ingredients Business Overview
  22. 6.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio
  24. 6.4.5 ABF Ingredients Recent Developments
  25. 6.5 DFE Pharma
  26. 6.5.1 DFE Pharma Company Information
  27. 6.5.2 DFE Pharma Business Overview
  28. 6.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio
  30. 6.5.5 DFE Pharma Recent Developments
  31. 6.6 Evonik
  32. 6.6.1 Evonik Company Information
  33. 6.6.2 Evonik Business Overview
  34. 6.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Evonik Orally Disintegrating Tablet Excipient Product Portfolio
  36. 6.6.5 Evonik Recent Developments
  37. 6.7 Merck KGaA
  38. 6.7.1 Merck KGaA Company Information
  39. 6.7.2 Merck KGaA Business Overview
  40. 6.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio
  42. 6.7.5 Merck KGaA Recent Developments
  43. 6.8 Ashland
  44. 6.8.1 Ashland Company Information
  45. 6.8.2 Ashland Business Overview
  46. 6.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ashland Orally Disintegrating Tablet Excipient Product Portfolio
  48. 6.8.5 Ashland Recent Developments
  49. 6.9 Meggle Pharma
  50. 6.9.1 Meggle Pharma Company Information
  51. 6.9.2 Meggle Pharma Business Overview
  52. 6.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio
  54. 6.9.5 Meggle Pharma Recent Developments
  55. 6.10 Shin-Etsu
  56. 6.10.1 Shin-Etsu Company Information
  57. 6.10.2 Shin-Etsu Business Overview
  58. 6.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio
  60. 6.10.5 Shin-Etsu Recent Developments
  61. 6.11 Fuji Chemical Industries
  62. 6.11.1 Fuji Chemical Industries Company Information
  63. 6.11.2 Fuji Chemical Industries Business Overview
  64. 6.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio
  66. 6.11.5 Fuji Chemical Industries Recent Developments
  67. 6.12 McePharma (Vivesa holding)
  68. 6.12.1 McePharma (Vivesa holding) Company Information
  69. 6.12.2 McePharma (Vivesa holding) Business Overview
  70. 6.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio
  72. 6.12.5 McePharma (Vivesa holding) Recent Developments
  73. 6.13 Cargill Incorporated
  74. 6.13.1 Cargill Incorporated Company Information
  75. 6.13.2 Cargill Incorporated Business Overview
  76. 6.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio
  78. 6.13.5 Cargill Incorporated Recent Developments
  79. 6.14 Daicel Corporation
  80. 6.14.1 Daicel Corporation Company Information
  81. 6.14.2 Daicel Corporation Business Overview
  82. 6.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio
  84. 6.14.5 Daicel Corporation Recent Developments
  85. 6.15 Anhui Sunhere Pharmaceutical
  86. 6.15.1 Anhui Sunhere Pharmaceutical Company Information
  87. 6.15.2 Anhui Sunhere Pharmaceutical Business Overview
  88. 6.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio
  90. 6.15.5 Anhui Sunhere Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Orally Disintegrating Tablet Excipient Sales by Country
  2. 7.1.1 North America Orally Disintegrating Tablet Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Orally Disintegrating Tablet Excipient Sales by Country (2021-2026)
  4. 7.1.3 North America Orally Disintegrating Tablet Excipient Sales Forecast by Country (2027-2032)
  5. 7.2 North America Orally Disintegrating Tablet Excipient Market Size by Country
  6. 7.2.1 North America Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Orally Disintegrating Tablet Excipient Market Size by Country (2021-2026)
  8. 7.2.3 North America Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Orally Disintegrating Tablet Excipient Sales by Country
  2. 8.1.1 Europe Orally Disintegrating Tablet Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Orally Disintegrating Tablet Excipient Sales by Country (2021-2026)
  4. 8.1.3 Europe Orally Disintegrating Tablet Excipient Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Orally Disintegrating Tablet Excipient Market Size by Country
  6. 8.2.1 Europe Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Orally Disintegrating Tablet Excipient Market Size by Country (2021-2026)
  8. 8.2.3 Europe Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Country
  2. 9.1.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Orally Disintegrating Tablet Excipient Market Size by Country
  6. 9.2.1 Asia-Pacific Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Orally Disintegrating Tablet Excipient Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Orally Disintegrating Tablet Excipient Sales by Country
  2. 10.1.1 South America Orally Disintegrating Tablet Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Orally Disintegrating Tablet Excipient Sales by Country (2021-2026)
  4. 10.1.3 South America Orally Disintegrating Tablet Excipient Sales Forecast by Country (2027-2032)
  5. 10.2 South America Orally Disintegrating Tablet Excipient Market Size by Country
  6. 10.2.1 South America Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Orally Disintegrating Tablet Excipient Market Size by Country (2021-2026)
  8. 10.2.3 South America Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country
  2. 11.1.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Orally Disintegrating Tablet Excipient Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Country
  6. 11.2.1 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Orally Disintegrating Tablet Excipient Value Chain Analysis
  2. 12.1.1 Orally Disintegrating Tablet Excipient Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Orally Disintegrating Tablet Excipient Production Mode & Process
  7. 12.2 Orally Disintegrating Tablet Excipient Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Orally Disintegrating Tablet Excipient Distributors
  10. 12.2.3 Orally Disintegrating Tablet Excipient Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst